AVR Anteris Technologies Global Corp.
Anteris Technologies Global Corp. (AVR) is expected to report earnings on November 10, 2026, after the market close. The stock has had a Post-Earnings Announcement Drift (PEAD) of +4.1% since its last earnings release on August 11, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Anteris Technologies Global Corp.
Anteris Technologies Global Corp. is involved in designing, developing and commercializing cutting-edge medical devices to restore healthy heart function. The company's lead product includes DurAVR(R). Anteris Technologies Global Corp. is based in BRISBANE, Australia.
Sector
Healthcare
Industry
Medical Instruments/Supply